The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

With this acquisition, LipoVation becomes a wholly owned subsidiary of Revium Rx, aligning with the company’s renewed commitment to drug delivery innovation. Revium Rx is developing a portfolio of ...

“At a time when fundamental rights are under attack across the country, we are doubling down on our commitment to safeguard ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is l ikely to drive up the cost of generic ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

A grand jury in Baton Rouge, Louisiana, has indicted and issued arrest warrants for a New York physician who prescribed ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

Jaguar Health (JAGX) and Napo Therapeutics announced that the first short bowel syndrome with intestinal failure patient has been dosed in the ...

A New York doctor has been indicted by a Louisiana grand jury for allegedly prescribing an abortion pill online in the state, ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.